HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wan Li Selected Research

viral interferon regulatory factors

11/2022A viral interferon regulatory factor degrades RNA-binding protein hnRNP Q1 to enhance aerobic glycolysis via recruiting E3 ubiquitin ligase KLHL3 and decaying GDPD1 mRNA.
5/2021Correction: An oncogenic viral interferon regulatory factor upregulates CUB domain-containing protein 1 to promote angiogenesis by hijacking transcription factor lymphoid enhancer-binding factor 1 and metastasis suppressor CD82.
12/2020An oncogenic viral interferon regulatory factor upregulates CUB domain-containing protein 1 to promote angiogenesis by hijacking transcription factor lymphoid enhancer-binding factor 1 and metastasis suppressor CD82.
1/2020Sperm associated antigen 9 promotes oncogenic KSHV-encoded interferon regulatory factor-induced cellular transformation and angiogenesis by activating the JNK/VEGFA pathway.
1/2019Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1/miR-218-5p network.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wan Li Research Topics

Disease

44Neoplasms (Cancer)
11/2022 - 02/2010
8Glioblastoma (Glioblastoma Multiforme)
11/2022 - 07/2018
6Inflammation (Inflammations)
09/2019 - 11/2014
5Carcinogenesis
11/2022 - 10/2016
5Breast Neoplasms (Breast Cancer)
07/2021 - 11/2013
5Neoplasm Metastasis (Metastasis)
05/2021 - 09/2015
4Cardiomyopathies (Cardiomyopathy)
01/2022 - 01/2013
4Glaucoma
10/2020 - 07/2010
4Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 11/2014
3Infections
11/2022 - 01/2020
3Pancreatic Neoplasms (Pancreatic Cancer)
04/2022 - 12/2014
3Adenocarcinoma
04/2022 - 02/2010
3Cognitive Dysfunction
01/2020 - 01/2017
3Colitis
02/2015 - 08/2011
2Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 02/2015
2Atherosclerosis
01/2021 - 01/2018
2Carcinoma (Carcinomatosis)
12/2020 - 10/2018
2Adenocarcinoma of Lung
11/2019 - 02/2010
2Stroke (Strokes)
10/2019 - 03/2019
2Prostatic Neoplasms (Prostate Cancer)
01/2019 - 04/2011
2Hyperplasia
09/2017 - 07/2010
2Fibrosis (Cirrhosis)
01/2017 - 05/2014
2Body Weight (Weight, Body)
08/2016 - 02/2012
2Cicatrix (Scar)
01/2012 - 01/2011
1Blister (Bulla)
04/2022
1Myeloid Leukemia (Leukemia, Myelocytic)
12/2021
1Pathologic Processes
09/2021
1Triple Negative Breast Neoplasms
07/2021
1Sepsis (Septicemia)
05/2021
1Brain Neoplasms (Brain Tumor)
01/2021
1Necrosis
01/2021
1Dehydration (Water Stress)
11/2020
1Bone Diseases (Bone Disease)
06/2020

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
10/2022 - 07/2010
16Biomarkers (Surrogate Marker)IBA
04/2022 - 12/2012
11Pharmaceutical PreparationsIBA
01/2022 - 04/2011
7MicroRNAs (MicroRNA)IBA
01/2019 - 01/2013
6Messenger RNA (mRNA)IBA
10/2022 - 12/2014
5viral interferon regulatory factorsIBA
11/2022 - 01/2019
5Biological ProductsIBA
04/2022 - 08/2010
4AcidsIBA
02/2020 - 08/2011
3Competitive Endogenous RNAIBA
01/2022 - 01/2019
3Long Noncoding RNAIBA
03/2020 - 12/2016
3Therapeutic UsesIBA
01/2020 - 08/2011
3AgarIBA
12/2019 - 01/2018
3CytokinesIBA
09/2019 - 02/2012
2Apolipoprotein C-I (Apolipoprotein C1)IBA
11/2022 - 08/2019
2SolutionsIBA
04/2022 - 04/2015
2GraphiteIBA
04/2022 - 10/2016
2CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
01/2022 - 10/2019
2Lymphoid Enhancer-Binding Factor 1IBA
05/2021 - 12/2020
2Transcription Factors (Transcription Factor)IBA
05/2021 - 12/2020
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 07/2018
2Neuroprotective AgentsIBA
01/2020 - 02/2016
2RNA (Ribonucleic Acid)IBA
11/2019 - 12/2016
2LuciferasesIBA
10/2018 - 03/2018
2Amino AcidsFDA Link
06/2018 - 01/2017
2EnzymesIBA
01/2018 - 03/2015
2Dimethylnitrosamine (Nitrosodimethylamine)IBA
01/2017 - 05/2014
2FibrinIBA
01/2012 - 01/2011
1Serine (L-Serine)FDA Link
10/2022
1SiliconIBA
04/2022
1BenzimidazolesIBA
01/2022
1AzolesIBA
01/2022
1Cyclic PeptidesIBA
01/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1flubendazoleIBA
01/2022
1antiglomerular basement membrane antibodyIBA
01/2022
1histone H3 trimethyl Lys4IBA
12/2021
1MethyltransferasesIBA
12/2021
1Glutamic Acid (Glutamate)FDA Link
12/2021
1Neuropilin-1IBA
12/2021
1Recombinant ProteinsIBA
12/2021
1Serine Proteases (Serine Protease)IBA
12/2021
1Glycoproteins (Glycoprotein)IBA
12/2021
1EstersIBA
11/2021
1sinomenineIBA
11/2021
1AlkaloidsIBA
11/2021
1Circular RNAIBA
09/2021
1Progesterone Receptors (Progesterone Receptor)IBA
07/2021
1Epidermal Growth Factor (EGF)IBA
07/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2021
1Estrogen ReceptorsIBA
07/2021
1Caspase 3 (Caspase-3)IBA
01/2021
1Caspase 9IBA
01/2021
1avasimibeIBA
01/2021
1Acyl Coenzyme A (Acyl CoA)IBA
01/2021
1CholesterolIBA
01/2021
1Phosphotransferases (Kinase)IBA
12/2020
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2020
1UbiquitinIBA
12/2020
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2020
1ElementsIBA
11/2020
1trabecular meshwork-induced glucocorticoid response proteinIBA
10/2020

Therapy/Procedure

8Therapeutics
09/2021 - 09/2011
2Immunotherapy
04/2022 - 06/2021
2Drug Therapy (Chemotherapy)
06/2021 - 02/2020
2Lasers (Laser)
01/2017 - 07/2010
2Trabeculectomy (Trabeculoplasty)
01/2012 - 01/2011
1Catheters
05/2021